No Data
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects Of ATH-1105 In Models Of ALS At Motor Neurone Disease Association's International Symposium On ALS/MND
Athena Gold Upsizes Private Placement From C$1M to up to C$1.25M
Athira Pharma's Regulatory Compliance Challenges Threaten Drug Development Pipeline
Althira Pharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results.
Express News | Althira Pharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results
JMP Securities Maintains Athira(ATHA.US) With Hold Rating
No Data
105642463xu : It's a good idea not to hold it overnight, otherwise you‘ll be doomed if you fall asleep like me.
msaf79 : just go for intraday trade..see money take money
Den the Dragon : Thanks for your work my friend
105095009 : should we trade overnight or pre market for SHIM?
Jaguar8 OP 105095009 : You have to decide on that. Read the note I included in this post
View more comments...